INDICATIONS FOR USE:
•
The Medcomp
vascular access for hemodialysis and apheresis in the adult population.
•
It may be inserted percutaneously and is primarily placed in the internal
jugular vein.
•
Alternate insertion sites include the subclavian vein and inferior vena cava
as required.
•
Catheters greater than 40cm are intended for femoral vein or inferior vena
cava insertion. Translumbar insertion via inferior vena cava is indicated when
all other access sites are identified as non-viable.
CONTRAINDICATIONS:
•
This catheter is intended for Long-Term vascular access only and should not
be used for any purpose other than indicated in these instructions.
DESCRIPTION:
•
The versatility of the Split Cath® III allows the lumens to be split to form two
free floating lumens to help eliminate catheter occlusion by the vessel.
•
The Split Cath® III is manufactured from soft radiopaque polyurethane
material which provides increased patient comfort while providing excellent
biocompatibility.
POTENTIAL COMPLICATIONS:
•
Air Embolus
•
Bacteremia
•
Brachial Plexus Injury
•
Cardiac Arrhythmia
•
Cardiac Tamponade
•
Central Venous Thrombosis
•
Endocarditis
•
Exit Site Infection
•
Exsanguination
•
Femoral Artery Bleed
•
Femoral Nerve Damage
•
Hematoma
•
Hemorrhage
•
Hemothorax
•
Inferior Vena Cava Puncture
•
Laceration of the Vessel
•
Lumen Thrombosis
•
Mediastinal Injury
•
Perforation of the Vessel
•
Pleural Injury
•
Pneumothorax
•
Retroperitoneal Bleed
•
Right Atrial Puncture
•
Septicemia
•
Subclavian Artery Puncture
•
Subcutaneous Hematoma
•
Superior Vena Cava Puncture
•
Thoracic Duct Laceration
•
Tunnel Infection
•
Vascular Thrombosis
•
Venous Stenosis
•
Before attempting the insertion, ensure that you are familiar with the potential
complications and their emergency treatment should any of them occur.
Split Cath
III is indicated for use in attaining Long-Term
®
®
-1-